-
Uncategorized2 months agoExpanding the Toolbox for Mammalian Genome Engineering
Sponsored content brought to you by Across biomanufacturing, disease modeling, synthetic biology, and cell therapy development, researchers increasingly need to insert large DNA constructs into mammalian...
-
Uncategorized2 months agoDetecting Disease at Its Molecular Origin
Sponsored content brought to you by Credit: Garage Brain Science Even for most of modern medicine, the beginning of a disease is synonymous with symptoms. A...
-
Uncategorized2 months ago
Scientists discover hidden “winds” inside cells that could explain cancer spread
Cells aren’t as passive as scientists once thought—they actively create internal currents to move proteins quickly and efficiently. These “cellular winds” push materials to the front...
-
Uncategorized2 months agoOpinion: Medical marijuana should not be recommended for PTSD, anxiety, or depression
Thirty-eight states plus the District of Columbia allow practitioners to recommend medical marijuana for post-traumatic stress disorder. But what if they’re all wrong? A new systematic review of results from randomized controlled trials...
-
Uncategorized2 months agoWhy an ovary syndrome may get a new name: Men seem to have PCOS, too
Few things will give a man as much of an insight into the female body as growing up with sisters. Painful, irregular periods, body hair, skin...
-
Uncategorized2 months ago
The Brave New World of Radiotherapeutics
The Brave New World of Radiotherapeutics
-
Uncategorized2 months ago
Phage Chemical “Crosstalk” Can Backfire, Steering Responders Into Lysogeny
Phages have been known to trade chemical messages to guide their life‑cycle decisions, but new research shows that some of those messages function more like Trojan...
-
Uncategorized2 months ago
Scalable homology detection with ERAST
Nature Biotechnology, Published online: 01 April 2026; doi:10.1038/s41587-026-03051-1 ERAST speeds up homology search and provides a vector database for 1 billion biological sequences.
-
Uncategorized2 months ago
Lilly Acquires Centessa for Up to $7.8B; Biogen Buys Apellis for Up to $6.1B
A pair of billion-dollar-plus buyout deals are in the works with Eli Lilly agreeing to acquire sleep disorder drug developer Centessa Pharmaceuticals for approximately $7.8 billion,...
-
Uncategorized2 months ago
Pharma goes on $25.5B, eight-day acquisition spree
Pharma goes on $25.5B, eight-day acquisition spree
STAT+: Up and down the ladder: The latest comings and goings
FDA imposes import alert on Indian plant after inspectors flag GMP failings
